公司概覽
業務類別 Biotechnology
業務概覽 Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.
公司地址 275 Shoreline Drive, Suite 500, Redwood City, CA, USA, 94065
電話號碼 +1 650 206-4507
傳真號碼 --
公司網頁 https://www.rezolutebio.com
員工數量 58
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Daron Evans Chief Financial and Business Officer 美元 480.00K 21/10/2026
Mr. Nevan Charles Elam, J.D. Acting Chairman of the Board and Chief Executive Officer 美元 655.00K 21/10/2026
Dr. Brian Kenneth Roberts, M.D. Chief Medical Officer 美元 512.16K 21/10/2026
Mr. Sunil Karnawat Chief Commercial Officer 美元 415.63K 21/10/2026
 
董事會成員
董事會 職務 更新日期
Mr. Gil M. Labrucherie, C.F.A.,J.D. Independent Director 21/10/2026
Mr. Nevan Charles Elam, J.D. Acting Chairman of the Board and Chief Executive Officer 21/10/2026
Mr. Philippe Fauchet Independent Director 21/10/2026
Dr. Nerissa C. Kreher, M.D. Independent Director 21/10/2026
Dr. Wladimir Hogenhuis, M.D. Independent Director 21/10/2026
Mr. Erik Harris Independent Director 21/10/2026
Mr. Young-jin Kim Director 21/10/2026
 
所屬ETF (更新日期: 07/11/2026 02:07)
代號 名稱 佔比% ▼ 持有日期
IWMiShares Russell 2000 ETF2.09%30/10/2026
IWNiShares Russell 2000 Value ETF0.66%30/10/2026
VTWOVanguard Russell 2000 ETF0.47%30/09/2026
SCHASchwab US Small-Cap ETF™0.42%31/10/2026
FESMFidelity Enhanced Small Cap Core ETF0.41%30/10/2026
VFMOVanguard US Momentum Factor ETF0.34%30/09/2026
DFASDimensional US Small Cap ETF0.33%02/10/2026
JSMLJanus Henderson Small Cap Gr Alpha ETF0.27%30/10/2026
IWCiShares Micro-Cap ETF0.24%30/10/2026
VHTVanguard Health Care ETF0.20%30/09/2026
GSSCGoldman Sachs ActiveBeta® US SmCp Eq ETF0.13%30/10/2026
ITOTiShares Core S&P Total US Stock Mkt ETF0.13%30/10/2026
SBIOALPS Medical Breakthroughs ETF0.12%30/10/2026
IWOiShares Russell 2000 Growth ETF0.10%30/10/2026
BBCVirtus Biotech Clinical Trials ETF0.07%30/10/2026
SCHBSchwab US Broad Market ETF™0.07%31/10/2026
VTWVVanguard Russell 2000 Value ETF0.06%30/09/2026
DFACDimensional US Core Equity 2 ETF0.05%02/10/2026
RUSCRussell Inv U.S. Small Cap Equity ETF0.03%31/10/2026
DFAUDimensional US Core Equity Market ETF0.02%30/10/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.